Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells.
8 Rue de la Croix Jarry, 75013 Paris, France
The Synthetic Genome, Synthetic Cells Tissues and Beyond
Founded in 2019, Oxfordshire, United Kingdom
© BioTechScope Ltd. All rights reserved